FindTrial
Sign In

The Study on protection of Cardiomyocyte Mediated by Endocannabinoid System during CPCR

The Study on protection of Cardiomyocyte Mediated by Endocannabinoid System during CPCR

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014836
Enrollment
Unknown
Registered
2018-02-08
Start date
2018-03-01
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrest

Interventions

Normal group:none
Control group:Similar disease
cardio-pulmonary resuscitation group:cardio-pulmonary resuscitation

Sponsors

Department of Anesthesiology, West China Hospital, Sichuan University,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with successful cardiopulmonary resuscitation in West China Hospital Sichuan University who are with the same type of disease, similar age, same gender, no respiratory arrest or healthy people; (2) Males or females 18 to 70 years of age; (3) Agree and sign informed consent.

Exclusion criteria

Exclusion criteria: (1) After 30 minutes cardiopulmonary resuscitation, patient did not recovery their spontaneous circulation (2) Patients with following diseases: immune system diseases, severe infections, Alzheimer's disease, leukemia, cancer or chronic liver diseases; (3) Patients using other test drugs or participating in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Plasma 2-AG;—

Countries

China

Contacts

Public ContactGuo Chen

Department of Anesthesiology, West China Hospital, Sichuan University,

894397461@qq.com+86 18980601577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026